Ophthalmology conditions Flashcards
AMD
Progressive disease affecting the macula classified by a number of physical characteristics, in particular the number and consistency of drusen
Most common cause of blindness in the UK
AMD risk factors
Age - AMD increases with age
Smoking
Caucasian
Concomitant diseases - CVD, HTN
Ocular characteristics - light iris, hyperopia
Genetics - complement factor H, gene variant Y402H
Dry AMD
Less aggressive form, accounts for between 80-90% of all AMD
Initially no apparent symptoms but drusen present
Visual loss caused by atrophy or conversion to wet AMD
Wet AMD
New vessels develop from the choroid layer and grow into the retina (neovascularisation)
Vessels can leak fluid or blood, causing oedema and faster vision loss
VEGF stimulates the development of new vessels
AMD vs glaucoma
Glaucoma - associated with peripheral vision loss and halos around lights
AMD - associated with central vision loss and a wavy appearance to straight lines
AMD presentation
Unilateral
Gradual loss of central vision
Reduced visual acuity
Crooked or wavy appearance to straight lines (metamorphopsia)
Gradually worsening ability to read small text
Wet AMD presents more acutely than dry AMD → can progress to complete vision loss within 2-3 years & bilateral disease
AMD examination
Reduced visual acuity using a Snellen chart
Scotoma (enlarged central area of vision loss)
Amsler grid test - used to assess for the distortion of straight lines seen in AMD
Drusen may be seen in fundoscopy
AMD Ix
Slit lamp examination - detailed view of the retina and macula
Optical CT - used to diagnose and monitor AMD
Fluorescein angiography - assess retina blood supply → shows oedema & neovascularisation in wet AMD
AMD management
Require specialist ophthalmology assessment and management
No specific treatment for dry AMD, reducing risk of progression:
- avoiding smoking
- controlling BP
- vitamin supplementation has some evidence in slowing progression
Wet AMD - anti-VEGF medications (eg. ranibizumab) block VEGF & slow the development of new vessels
- injected directly into the vitreous chamber of the eye, usually about once a month
Charles Bonnet syndrome
Causes a person whose vision has started to deteriorate to see things that aren’t real
Brain doesn’t receive as much information as it used to and responds by filling in the gaps with fantasy patterns or images that it’s stored
Reassuring patients is essential to help them cope with hallucinations
Uveitis classification
Anatomical location - anterior (iris), intermediate (ciliary body), posterior (choroid)
Granulomatous vs non-granulomatous
Acute, recurrent or chronic
- recurrent - more than 3 months
- chronic - less than 3 months
Uveitis aetiology
Autoimmune - sarcoid, SLE, MS, Behcets, seronegative spondyloarthropathies, IBD
Infectious - CMV, HSV, HZV, candida, toxoplasma
Drug induced - bisphosphonates
Traumatic
Anterior uveitis clinical features
Symptoms - blurring of vision, pain, photophobia, redness of eye, floaters
Signs - keratic precipitates, cells in anterior chamber, fibrin in anterior chamber, flare in anterior chamber, posterior synechae (posterior part of the iris can get stuck to the lens during inflammation), cells in vitreous, choroiditis lesions, macular oedema
Uveitis investigations
Infectious vs non infectious
FBC, U&Es, LFT, Q Gold (TB), treponemal antibody (syphilis)
Other investigations dependent on suspected cause
Uveitis management
Anterior uveitis - topical steroids/subconjunctival steroids, cycloplegics
- cycloplegics - dilate the pupil & reduce pain associated with ciliary spasm
- topical steroids SE: ocular hypertension → glaucoma, posterior subcapsular cataract
Intermediate and posterior uveitis
- local treatment: periocular steroids, intravitreal steroid implants
- systemic treatment: pulse therapy, oral steroids, immunosuppression, aetiology specific antibiotic/antifungal/antiviral
- SE of steroids: insomnia, weight gain, osteoporosis, hyperglycaemia, immunosuppression, hypertension
Anterior uveitis complications
Posterior synechiae
Pupillary membrane
Ocular hypertension/glaucoma
Hypotony → no treatment so will lead to blindness
Cataract
Cystoid macular oedema
Glaucoma
Glaucoma - refers to optic nerve damage (characteristic optic head changes), associated with corresponding visual field defects, with or without raised intraocular pressure
Raised pressure caused by a blockage in aqueous humour trying to escape the eye
Main cause of irreversible blindness in the world
Two types: open-angle glaucoma, acute angle-closure glaucoma
Open-angle glaucoma pathophysiology
Gradual increase in resistance to flow through the trabecular meshwork
Pressure slowly builds within the eye
Raised intraocular pressure causes cupping of the optic disc → cup-disk ratio > 0.5 is abnormal
Open-angle glaucoma risk factors
Increasing age
Family history
Black ethnic origin
Myopia (nearsightedness)
Eye injuries/eye operations
Ocular hypertension
Open-angle glaucoma presentation
Rise in intraocular pressure may be asymptomatic for a long time & diagnosed by routine eye testing
Glaucoma affects the peripheral vision first → gradual onset of peripheral vision loss (tunnel vision)
Fluctuating pain
Headaches
Blurred vision
Halos around lights, particularly at night
Measuring intraocular pressure
Non-contact tonometry: estimates intraocular pressure by opticians; involves shooting a ‘puff of air’ at the cornea
Goldmann applanation tonometry - gold-standard to measure intraocular pressure → involves a device mounted on a slip lamp that makes contact with the cornea & applies various pressures
Open-angle glaucoma diagnosis
Goldmann applanation tonometry
Slit lamp
Visual field assessment
Gonioscopy
Central corneal thickness
Open-angle glaucoma management
360 degrees selective laser trabeculoplasty → laser directed at the trabecular meshwork, improving drainage
- may delay/prevent the need for eye drops
Next line: prostaglandin analogue eye drops (latanoprost) - increase uveoscleral outflow
- SE: eyelash growth, eyelid pigmentation, iris pigmentation
Other eye drop options: beta-blockers, carbonic anhydrase inhibitors, sympathomimetics
Open-angle glaucoma surgery
360 degree selective laser trabeculoplasty (SLT) first line to people with an IOP > 24mmHg
Trabeculectomy may be considered in refractory cases